SAN JOSE, Calif., Oct. 27 /PRNewswire-FirstCall/ -- HPSI (OTC Bulletin
Board: EROX) releases letter to its shareholders
In light of events that have shaken the investment community around the
world over the past several weeks, I want to take this opportunity to
update you as to what is happening in your Company at the present time.
Excluding technology advancements, an update of which will be provided
very shortly in another release, the objectives and strategies for the
Company for this year and 2009 are as follows:
-- The Company is continuing to work closely with our current licensees as
they undertake programs to introduce consumer products containing our
During this year we have continued to be closely involved with the J&J
Personal Products Group as they continue product development efforts
under our License Agreement. This project is ongoing and viable.
In mid 2007, we entered into an agreement with Schwarzkopf and Henkel,
for the inclusion of our patented technology in several of their got2b
brand products sold in the United States. During this year, the
Agreement has been expanded geographically to include Henkel's European
businesses and an additional product line has been included in the
We continue, this year, to work with other U.S. and international
companies including Avon Products, who continue to utilize our
pheromone compounds. In addition, we continue to look
internationally, and continue to enter into agreements with companies
doing business in Mexico and Japan.
In addition, we are in discussions with several other companies in the
United States and overseas, in efforts to open new markets for our
current technology with local companies, with their own infras
|SOURCE Human Pheromone Sciences, Inc.|
Copyright©2008 PR Newswire.
All rights reserved